[HTML][HTML] Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low …
S Mahmud, R Baral, C Sanderson, C Pecenka, M Jit… - BMC medicine, 2023 - Springer
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson… - BMC …, 2023 - researchonline.lshtm.ac.uk
BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of respiratory disease
in young children. A number of mathematical models have been used to assess the cost …
in young children. A number of mathematical models have been used to assess the cost …
[PDF][PDF] Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income …
S Mahmud, R Baral, C Sanderson, C Pecenka, M Jit… - 2023 - core.ac.uk
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson, C Pecenka, M Jit… - BMC Medicine, 2023 - europepmc.org
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson… - BMC …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
[HTML][HTML] Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low …
S Mahmud, R Baral, C Sanderson… - BMC …, 2023 - bmcmedicine.biomedcentral.com
Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in young children.
A number of mathematical models have been used to assess the cost-effectiveness of RSV …
A number of mathematical models have been used to assess the cost-effectiveness of RSV …
[HTML][HTML] Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low …
S Mahmud, R Baral, C Sanderson, C Pecenka… - BMC …, 2023 - ncbi.nlm.nih.gov
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson, C Pecenka… - BMC …, 2023 - search.proquest.com
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson, C Pecenka… - BMC …, 2023 - search.ebscohost.com
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and …
S Mahmud, R Baral, C Sanderson, C Pecenka, M Jit… - BMC Medicine, 2023 - europepmc.org
Background Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in
young children. A number of mathematical models have been used to assess the cost …
young children. A number of mathematical models have been used to assess the cost …